Results 121 to 130 of about 32,071 (158)

Risk Factors for Liver Injury and Their Association with Treatment in Hospitalized Patients with COVID-19. [PDF]

Intern Med
Kato C, Ito Y, Mori Y, Ito K, Fukumitsu K, Fukuda S, Kanemitsu Y, Uemura T, Tajiri T, Ohkubo H, Oguri T, Nakamura A, Niimi A.   +12 more
europepmc   +1 more source

Remdesivir [PDF]

Reactions Weekly, 2020
openaire   +1 more source

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients. [PDF]

PNAS Nexus
Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A.   +29 more
europepmc   +1 more source

Medical rationing choices of laypeople and clinicians are often illogical and inconsistent with their own stated preferences. [PDF]

PLoS One
Heydari P, Meyer MN, Chabris CF.
europepmc   +1 more source

Investigating outcomes and treatment of long coronavirus disease 2019 in patients with multiple sclerosis treated with rituximab: A case series study. [PDF]

J Res Med Sci
Shirani K, Khorvash F, Karamshahi A, Maghamimehr A.   +3 more
europepmc   +1 more source

Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated. [PDF]

Children (Basel)
Nieves DJ, Tran MT, Singh J, Ashouri N, Morphew T, Lusk JG, Adler-Shohet FC, Marano R, Osborne S, Strickland J, Arrieta AC.   +10 more
europepmc   +1 more source

Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance. [PDF]

BMC Infect Dis
Rotundo S, Serapide F, Berardelli L, Gullì SP, Mongiardi S, Tassone MT, Trecarichi EM, Russo A.   +7 more
europepmc   +1 more source

COVID-19 management in patients with comorbid conditions. [PDF]

World J Virol
Sanyaolu A, Okorie C, Marinkovic A, Prakash S, Balendra V, Lehachi A, Abbasi AF, Haider N, Abioye A, Orish VN, Antonio A, Badaru O, Pandit R, Izurieta R.   +13 more
europepmc   +1 more source

Construction and validation of a cell based reporter assay for identifying inhibitors of SARS coronavirus 2 RNA dependent RNA polymerase activity. [PDF]

Sci Rep
Kang E, Yoon H, Lee J, Lee J, Kim S, Jo I, Han SB, Jeong DG, Cho S.   +8 more
europepmc   +1 more source

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave. [PDF]

BMC Infect Dis
La YJ, Oh WS, Kim C, Lim MN, Jeon YD.
europepmc   +1 more source